Botulinum Toxin Type A to Improve Facial Symmetry

Irrespective of its origin, whether it's idiopathic or a secondary occurrence, facial nerve palsy, which could stem from various causes, presents as a one-sided paralysis of the peripheral facial nerve. This can result in involuntary changes in facial expression, both in terms of stillness and movement. The options for treating facial nerve palsy generally revolve around stimulating the muscles responsible for facial expressions on the affected side or enhancing symmetry on both sides. These approaches can range from non-invasive methods like medication and physical therapy to more invasive procedures.
One notable pharmacological treatment is the administration of botulinum toxin type A (BoNT-A), a practice introduced as early as 1987, involving injecting it into the non-affected side. A team of authors from Brazil has laid out a practical guide for utilizing botulinum toxin in cases of facial palsy. The ease of administering the injection and the adaptable injection points allow for a personalized and tailor-made treatment regimen. Furthermore, positive results are noticeable within a short span of time, and the effects may have a lasting impact. It's important to consider the injection technique to minimize unwanted effects and enhance effectiveness. The precise location of the injection, along with the depth and angle of the needle during the procedure, holds utmost significance, as the thickness of muscle-skin units can vary. It's essential to comprehend the diffusion properties of the specific BoNT-A variant chosen, as different types of botulinum toxin might exhibit distinct characteristics. For a comprehensive understanding, refer to the complete details provided in the original article.